Advances in targeted therapy for acute myeloid leukemia

Biomarker Research

Table 3 Current clinical trials of Ponatinib for leukemia patients

ClinicalTrials. gov Identifier	Phase	Enrollment Number	Disease Conditons	Status	Lead Institution/Location
NCT02398825	2	78	CML	Active, recruiting	Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto, Italy
NCT04048564	Observational	150	CML	Active, recruiting	CHU SUD Reunion GHSR, France
NCT03807479	2	54	CML	Active, recruiting	University Hospital RWTH Aachen, Germany
NCT02627677	3	44	CML	Active, not recruiting	Cliniques Universitaire Saint Luc, Belgium
NCT01641107	2	44	BCR-ABL+ ALL	Active, not recruiting	S.O.C. di Ematologia, Italy
NCT03934372	1,2	60	AML, ALL All Phase CML Solid Tumors	Active, recruiting	UZ Gent, Belgium
NCT03933852	Observational	100	CML	Active, recruiting	University Hospital Jena, Germany
NCT03678454	Observational	125	CML Ph + ALL	Active, recruiting	ZNA Stuyvenberg, Belgium
NCT03147612	2	60	Accelerated Phase CML BCR-ABL1+ R/R ALL	Active, recruiting	M D Anderson Cancer Center, USA
NCT01746836	2	50	Chronic Phase CML BCRABL1+ Recurrent CML BCRABL1+	Active, not recruiting	M D Anderson Cancer Center, USA

ISSN: 2050-7771